Drug that could tackle Omicron variant approved by UK regulators

Drug that could tackle Omicron variant approved by UK regulators

A drug treatment which, the makers say, works against the new Omicron variant of Covid-19 has been approved by UK regulators.

Xevudy (sotrovimab), made by pharmaceutical giant GlaxoSmithKline (GSK), has been found to cut hospital admission and death by 79% in those at risk.

The monoclonal antibody has been authorised by the Medicines and Healthcare products Regulatory Agency for people with mild to moderate Covid-19 who are at high risk of developing severe disease.

It comes as GSK and Vir Biotechnology said preclinical data shows the drug “retains activity against key mutations of the new Omicron Sars-CoV-2 variant”.

The UK Government has ordered around 100,000 doses of the drug.

Published: by Radio NewsHub
Start your relationship

If you are interested in receiving bulletins from Radio News Hub or would simply like to find out more please fill in the form below.

We aim to get back to you within 48 hours